Cocrystal Pharma
COCP
22 hedge funds and large institutions have $831K invested in Cocrystal Pharma in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 22 → 22 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0.28% less ownership
Funds ownership: 6.75% → 6.47% (-0.28%)
19% less capital invested
Capital invested by funds: $1.02M → $831K (-$192K)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$49.2K |
| 2 |
Jane Street
New York
|
+$32.5K |
| 3 |
Renaissance Technologies
New York
|
+$4.47K |
| 4 |
Citigroup
New York
|
+$1.63K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$60.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$32.9K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$21K |
| 4 |
PA
Parallel Advisors
San Francisco,
California
|
-$4.04K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$563 |
COCP Hedge Fund Activity: Q3 2025 in Review
22 of the 7,645 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q3 2025, worth a combined $831K — down 19% from $1.02M a quarter earlier.
Fund positioning in COCP was balanced in Q3 2025: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 4 trimmed.
The largest buyer was Neuberger Berman Group, opening a new position worth an estimated $49.2K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $60.5K sold.
- 22 institutional investors held Cocrystal Pharma (COCP) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $831K of Cocrystal Pharma stock for Q3 2025, down 19% quarter-over-quarter.
- 4 funds opened new Cocrystal Pharma positions in Q3 2025 and 4 closed out, a net change of 0 holders.
- The largest Cocrystal Pharma buyer in Q3 2025 was Neuberger Berman Group, an estimated $49.2K added.
- The largest Cocrystal Pharma seller in Q3 2025 was Susquehanna International Group, an estimated $60.5K sold.
Based on aggregated 13F filings for Q3 2025.